bleeding timeclotting-time-pt-and-ptt
TRANSCRIPT
![Page 1: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/1.jpg)
COGULATION PROFILE
Bleeding time, clotting time, PT, and PTT
Presented By HUSSAIN AKHTAR
![Page 2: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/2.jpg)
WHAT IS COAGULATION?Coagulation is a complex process by which blood forms clots.
Blood must be remain fluid with in the vasculature and yet clot quickly when expose to non endothelial surface at a site of vascular injury.
It is an important part of haemostasis (the cessation of blood loss from a damaged vessel), where in a damaged blood vessel wall is covered by a platelet and fibrin-containing clot to stop bleeding and begin repair of the damaged vessel.
Disorders of coagulation can lead to an increased risk of bleeding (hemorrhage) or clotting (thrombosis).
![Page 3: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/3.jpg)
Hemostasis is maintained in the body via three mechanisms: Vascular spasm - Damaged blood vessels. constrictPlatelet plug formation - Platelats
adhere to damaged endothelium to form platelet plug (primary hemostasis) and then degranulate.
Blood Coagulation - Clots form upon the conversion of fibrinogen to Fibrin, and its addition to the platelet plug (secondary hemostasis).
![Page 4: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/4.jpg)
Factor IFibrinogenFactor VIIIAntihemophilic globulin
Factor IIProthrombinFactor IXPartial thromboplastin component
Factor IIIThromboplastin
Factor XStuart-Prower factor
Factor IVCalciumFactor XIPlasma thromboplastin antecedent
Factor VLabile or proaccelerin
Factor XIIHageman factor
Factor VIIStable factor or proconvertin
Factor XIIIFibrin-stabilizing factor
![Page 5: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/5.jpg)
THE CLOTTING MECHANISM
INTRINSIC EXTRINSC
PROTHROMBIN THROMBIN
FIBRINOGEN
FIBRIN(II) (III)
(I)V
X
Tisue ThromboplastinCollagen
VII
XII
XI
IXVIII
![Page 6: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/6.jpg)
FIBRINOLYTIC PHASE
ANTICLOTTING MECHANISMS ARE ACTIVATED TO ALLOW CLOT DISINTEGRATION AND REPAIR OF THE DAMAGED VESSEL.
![Page 7: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/7.jpg)
HEMOSTASISDEPENDENT UPON:
Vessel Wall Integrity Adequate Numbers of Platelets Proper Functioning Platelets Adequate Levels of Clotting Factors Proper Function of Fibrinolytic Pathway
![Page 8: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/8.jpg)
So What Causes Bleeding Disorders?
VESSEL DEFECTS
PLATELET DISORDERS
FACTOR DEFICIENCIES
![Page 9: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/9.jpg)
VESSEL DEFECTS VITAMIN C DEFICIENCY BACTERIAL & VIRAL INFECTIONS ACQUIRED
![Page 10: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/10.jpg)
PLATELET DISORDERS
THROMBOCYTOPENIA (INADEQUATE NUMBER OF PLATELETS)
Causes DRUG INDUCED BONE MARROW FAILURE HYPERSPLENISM OTHER CAUSES
![Page 11: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/11.jpg)
THROMBOCYTOPATHY ) ADEQUATE NUMBER BUT ABNORMAL
FUNCTION )
causes UREMIA INHERITED DISORDERS MYELOPROLIFERATIVE DISORDERS
DRUG INDUCED(ASPIRIN, NSAIDS)
![Page 12: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/12.jpg)
FACTOR DEFICIENCIES Inherited:
1. HEMHHHHOPHILIA A
2. HEMOPHILIA B
3. VON WILLEBRAND’S DISEASE
Acquired:
1. Anticoagulant therapy
2. Liver diseases
3. DIC
![Page 13: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/13.jpg)
LABORATORY EVALUATIONPLATELET COUNTBLEEDING TIME (BT)Clotting time (CT)PROTHROMBIN TIME (PT)Activated PARTIAL THROMBOPLASTIN
TIME (APTT)
![Page 14: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/14.jpg)
PLATELET COUNT (CBC)
NORMAL 100,000 - 400,000 CELLS/MM3
< 100,000 Thrombocytopenia
50,000 - 100,000 Mild Thrombocytopenia
< 50,000 Sever Thrombocytopenia
![Page 15: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/15.jpg)
BLEEDING TIME
PROVIDES ASSESSMENT OF PLATELET COUNT AND FUNCTION
NORMAL VALUE
2-8 MINUTES
![Page 16: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/16.jpg)
Clotting time - capillary method Material
1. Sterile disposable pricking needle or lancet. 2. Stop watch 3. Dry glass capillary tube (narrow diameter 1 top 2 mm,
minimum 10 cm long.) 4. Cotton Swab of absorbent cotton. 5. Spirit wetted, cotton swab. 6. 70 % v/v ethyl alcohol
![Page 17: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/17.jpg)
Clotting time of whole blood
![Page 18: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/18.jpg)
Clotting Time - Slide Method
• The surface of the glass tube initiates the clotting process. This test is sensitive to the factors involved in the intrinsic pathway
• The expected range for clotting time is 4-10 min.
![Page 19: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/19.jpg)
PROTHROMBIN TIMEPROTHROMBIN TIME
Measures Effectiveness of the Extrinsic Measures Effectiveness of the Extrinsic PathwayPathway
NORMAL VALUENORMAL VALUE
10-15 SECS10-15 SECS
![Page 20: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/20.jpg)
PTThe prothrombin time: is therefore the time required for the plasma
to clot after an excess of thromboplastin and an optimal concentration of calcium have been added.
Measures the function of the Extrinsic Pathway. Sensitive to Factors I, II, V, VII, X.
The PT evaluates patients suspected of having an inherited or acquired deficiency in these pathways.
![Page 21: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/21.jpg)
THE CLOTTING MECHANISM
INTRINSIC EXTRINSC
PROTHROMBIN THROMBIN
FIBRINOGEN
FIBRIN(II) (III)
(I)V
X
Tisue ThromboplastinCollagen
VII
XII
XI
IXVIII
![Page 22: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/22.jpg)
When is it ordered?Used to monitor oral anticoagulant therapy (Warfarin /
Coumadin).
When a patient who is not taking anti-coagulant drugs has signs or symptoms of a bleeding disorder.
When a patient is to undergo an invasive medical procedure, such as surgery, to ensure normal clotting ability.
![Page 23: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/23.jpg)
An elevated prothrombin time may indicate the presence of:
Vitamin K deficiency(Vitamin K is needed to make prothrombin and other clotting factors)
DIC liver disease a deficiency in one or more of the following factors:
I, II, V, VII, X. Anticoagulant (warfarin)
![Page 24: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/24.jpg)
INRA PT test may also be called an INR test. INR (international normalized ratio) stands for a way of
standardizing the results of prothrombin time tests, no matter the testing method.
So your doctor can understand results in the same way even when they come from different labs and different test methods.
Using the INR system, treatment with (anticoagulant therapy) will be the same. In some labs, only the INR is reported and the PT is not reported
![Page 25: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/25.jpg)
An INR of 1.0 means that the patient PT is normal.An INR greater than 1.0 means the clotting time is
elevated.INR of greater than 5 or 5.5 = unacceptable high risk of
bleeding,whereas if the INR=0.5 then there is a high chance of having a clot.
Normal range for a healthy person is 0.9–1.3, and for people on warfarin therapy, 2.0–3.0, although the target INR may be higher in particular situations, such as for those with a mechanical heart valve.
![Page 26: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/26.jpg)
PARTIAL THROMBOPLASTIN TIME Measures Effectiveness of the Intrinsic
Pathway
NORMAL VALUENORMAL VALUE
25-40 SECS25-40 SECS
![Page 27: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/27.jpg)
PTTThe partial thromboplastin time (PTT) or activated partial
thromboplastin time (aPTT or APTT( is a performance indicator measuring the efficacy of both the "intrinsic" and the common coagulation pathways.
It is also used to monitor the treatment effects with heparin a major anticoagulant.
Kaolin cephalin clotting time (KccT) is a historic name for the activated partial thromboplastin time
![Page 28: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/28.jpg)
THE CLOTTING MECHANISMINTRINSIC EXTRINSC
PROTHROMBIN THROMBIN
FIBRINOGEN
FIBRIN(II) (III)
(I)V
X
Tisue ThromboplastinCollagen
VII
XII
XI
IXVIII
![Page 29: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/29.jpg)
Normal PTT times require the presence of the following coagulation factors:
I, II, III, IV, V, VI, VIII, IX, X, XI, & XII
![Page 30: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/30.jpg)
When is it ordered?
When a patient presents with unexplained bleeding or bruising,
It may be ordered as part of a pre-surgical evaluation for
bleeding tendencies,
When a patient is on intravenous (IV) or injection heparin
therapy, the APTT is ordered at regular intervals to monitor the degree of anticoagulation.
![Page 31: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/31.jpg)
Prolonged APTT may indicate: Use of heparin.
antiphospholipid antibody:especially lupus anticoagulant, which paradoxically increases propensity to thrombosis
coagulation factor deficiency ,
e.g hemophilia DICLiver disease
![Page 32: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/32.jpg)
![Page 33: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/33.jpg)
FACTOR DEFICIENCIES Inherited:
1. HEMOPHILIA A
2. HEMOPHILIA B
3. VON WILLEBRAND’S DISEASE
Acquired:
1. Anticoagulant therapy
2. Liver diseases
3. DIC
![Page 34: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/34.jpg)
HEMOPHILIA A (Classic Hemophilia)
80-85% of all Hemophiliacs Deficiency of Factor VIII Lab Results - Prolonged PTT
![Page 35: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/35.jpg)
HEMOPHILIA B (Christmas Disease)
10-15% of all Hemophiliacs Deficiency of Factor IX Lab Test - Prolonged PTT
![Page 36: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/36.jpg)
VON WILLEBRAND’S DISEASE Deficiency of VWF & amount of Factor VIII Factor VIII is bound to vWF while inactive in
circulation; Factor VIII degrades rapidly when not bound to vWF
Lab Results - Prolonged BT, PTT
![Page 37: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/37.jpg)
ANTICOAGULANTS An anticoagulant is a substance that prevents
coagulation; that is, it stops blood from clotting This prevents deep vein thrombosis, pulmonar
embolism, myocardial infarction and stroke.
ANTICOAGULANTS1. Coumadins (Vitamin K antagonists)2. Heparin
![Page 38: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/38.jpg)
Coumadin's
These oral anticoagulants that antagonize the effects of vitamin K.
Examples include warfarin. It takes at least 48 to 72 hours for the anticoagulant effect to develop. Where an immediate effect is required, heparin must be given concomitantly.
Monitored by PT timesThese anticoagulants are used to treat patients
with deep-vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), and mechanical prosthetic heart valves.
![Page 39: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/39.jpg)
HeparinHeparin is a biological substance. It works by activating antithrombin III, which
blocks thrombin from clotting blood.Heparin Therapy is Monitored by PTT times Low molecular weight heparin is a more highly
processed product that is useful as it does not require monitoring of the APTT coagulation parameter (it has more predictable plasma levels) and has fewer side effects.
![Page 40: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/40.jpg)
Liver Disease
Liver Disease can Result in Reduced Production of Coagulation Factors (I,II,V,VII,IX,X).
![Page 41: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/41.jpg)
DICDisseminated intravascular coagulation (DIC is a
pathological activation of coagulation) blood clotting) mechanisms that happens in response to a variety of diseases
DIC leads to the formation of small blood clots inside the blood vessels throughout the body
The small clots also disrupt normal blood flow to organs (such as the kidneys), which may malfunction as a result
![Page 42: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/42.jpg)
As the small clots consume coagulation proteins and platelets, normal coagulation is disrupted and abnormal bleeding occurs from the skin the gastrointestinal tract, the respiratory tract and surgical wounds.
The PT and APTT are usually very prolonged and the fibrinogen level markedly reduced
High levels of fibrin degradation products, including D-dimer, are found owing to the intense fibrinolytic activity stimulated by the presence of fibrin in the circulation.
![Page 43: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/43.jpg)
Definitive diagnosis depends on the result of DIC:
Thrombocytopenia) prolonged bleeding time) Prolongation of prothrombin time and activated
partial thromboplastin time A low fibrinogen concentration Increased levels of fibrin degradation products
![Page 44: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/44.jpg)
Pre-analytic errors
Problems with blue-top tube Partial fill tubes Vacuum leak and citrate
evaporation
Problems with phlebotomy Heparin contamination Wrong label Slow fill Underfill Vigorous shaking
Biological effects•Hct ≥55 or ≤15
•Lipemia, hyperbilirubinemia, hemolysis
Laboratory errors•Delay in testing
•Prolonged incubation at 37°C
•Freeze/thaw deterioration
![Page 45: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/45.jpg)
![Page 46: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/46.jpg)
![Page 47: Bleeding timeclotting-time-pt-and-ptt](https://reader037.vdocuments.net/reader037/viewer/2022103016/554afb74b4c905c12d8b49c8/html5/thumbnails/47.jpg)